Publications by authors named "Emily Colbeck"

Claim this Profile
T
Therapeutic Potential of TLR8 Agonist GS-9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators.
Oliver E Amin, Emily J Colbeck, Stephane Daffis, Shahzada Khan, Dhivya Ramakrishnan

Hepatology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?
Emily Jayne Colbeck, Ann Ager, Awen Gallimore, Gareth Wyn Jones

Front Immunol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.
Emily J Colbeck, Emma Jones, James P Hindley, Kathryn Smart, Ralph Schulz

Cancer Immunol Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-2 tissue-resident T cells in the human liver: Sentinels for hepatotropic infection.
Laura J Pallett, Jessica Davies, Emily J Colbeck, Francis Robertson, Navjyot Hansi

J Exp Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.
Emily J Colbeck, James P Hindley, Kathryn Smart, Emma Jones, Anja Bloom

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A distinct chemokine axis does not account for enrichment of Foxp3(+)  CD4(+) T cells in carcinogen-induced fibrosarcomas.
Beatrice Ondondo, Emily Colbeck, Emma Jones, Kathryn Smart, Sarah N Lauder

Immunology· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses.
Melvyn W Yap, Emily Colbeck, Scott A Ellis, Jonathan P Stoye

PLoS Pathog· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis